Download presentation
Presentation is loading. Please wait.
Published byRebeka Kis Modified over 6 years ago
1
The ABLATE Trial: Safety and Efficacy of Cox Maze-IV Using a Bipolar Radiofrequency Ablation System
Jonathan M. Philpott, MD, Christian W. Zemlin, PhD, James L. Cox, MD, Mack Stirling, MD, Michael Mack, MD, Robert L. Hooker, MD, Allen Morris, MD, David A. Heimansohn, MD, James Longoria, MD, Divyakant B. Gandhi, MD, Patrick M. McCarthy, MD The Annals of Thoracic Surgery Volume 100, Issue 5, Pages (November 2015) DOI: /j.athoracsur Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 AtriCure Synergy clamp (a) and jaw geometry (b). Dimensions shown are for large jaws; small jaws have lower height (2.098 inches = mm) and otherwise identical dimensions. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Lesion set specified by the AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation (ABLATE) protocol: (A) left atrial lesions; (B) right atrial lesions. (CS = coronary sinus.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
4
Fig 3 Efficacy endpoint results. Error bars indicate 95% confidence interval as computed by the Wilson score method. (AAD = antiarrhythmia drug; AF = atrial fibrillation.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.